![Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity — Michigan Poison Center Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity — Michigan Poison Center](https://images.squarespace-cdn.com/content/v1/5f777ef4c9213f4b5800fc9a/1648041801547-99AV433TUWNMUYWIP3KV/white+pills+in+bottel.jpg)
Sandoz, Inc. Issues Nationwide Recall of 13 Lots of Orphenadrine Citrate 100 mg Extended Release Tablets Due to Presence of a Nitrosamine Impurity — Michigan Poison Center
![Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements | CPSC.gov Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements | CPSC.gov](https://www.cpsc.gov/s3fs-public/styles/recall_product/public/1577_1.jpeg?VersionId=h71TQ87irxSe1reK9.aTlii2UfM6y3tY&itok=mBwfBJP3)
Sandoz Recalls Losartan Potassium and Ezetimibe Prescription Drug Bottles Due to Failure to Meet Child-Resistant Closure Requirements | CPSC.gov
![Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements | CPSC.gov Sandoz and Novartis Recall Prescription Drug Blister Packages Due to Failure to Meet Child-Resistant Closure Requirements | CPSC.gov](https://www.cpsc.gov/s3fs-public/styles/recall_product/public/Picture1_48.png?VersionId=tERDr1OXBj1hiqxUDBjA60eIBULWeXKd&itok=NFGS30-1)